CVS' Q4 2025 saw record revenue, but rising medical costs in Aetna drove a $1B cut to FY 2026 cash flow guidance, now at $9B.

CVS Health delivered a stronger-than-expected fourth quarter, beating Wall Street estimates on both earnings and revenue as the company presses ahead with a multi-year turnaround. The results ...

The results signal steady progress in the health-care giant's aggressive turnaround plan under CEO David Joyner, who stepped into the role in late 2024.

Dry scalp and dandruff usually have different causes and treatments. Dermatologists explain the difference between the two and how to best treat each one.

Meanwhile, Ulta Beauty straddles both ends of the market. It stocks cheaper brands, such as e.l.f and Maybelline, alongside higher-end companies that Sephora also sells - such as Rihanna's Fenty ...